search
Back to results

Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs

Primary Purpose

Back Pain

Status
Unknown status
Phase
Phase 1
Locations
Israel
Study Type
Interventional
Intervention
phenol
Sponsored by
Assaf-Harofeh Medical Center
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Back Pain focused on measuring Methylprednisolone, trans sacral block, phenol

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: -at least 18 years of age;

  • chronic low back pain of at least 12 weeks duration;
  • patients which were diagnosed as a candidate for epidural since other techniques have failed to provide adequate pain control
  • Sciatica due to Lumbar Disc Herniation
  • Neurogenic Claudication due to Lumbar Spinal Stenosis

Exclusion Criteria:

  • patients with unbalanced high blood pressure
  • patients who can not ley prone
  • patients who consumes anti-clotting medications
  • patients with bleeding problems
  • patients with Diabetes
  • patients who suffers from chronic non-specific lower back and limb pain

Sites / Locations

  • Assaf Harofeh Medical CenterRecruiting

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
November 6, 2011
Last Updated
November 8, 2011
Sponsor
Assaf-Harofeh Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT01468415
Brief Title
Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs
Official Title
Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs
Study Type
Interventional

2. Study Status

Record Verification Date
May 2011
Overall Recruitment Status
Unknown status
Study Start Date
June 2011 (undefined)
Primary Completion Date
June 2013 (Anticipated)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assaf-Harofeh Medical Center

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The American Society of Anesthesiologists Task Force on Management, Chronic Pain section, recommended Phenol neurolysis when other techniques have failed to provide adequate pain control. In this study we sought to Compare the pain relieve on a Lower Back and Limbs obtained from Methylprednisolone and Phenol 8% Treatment given by Trans Sacral Approach. The study includes patients who suffers from a chronic low back and/or limbs pain which were referred to be given epidural as a treatment. Control group receives 80 mg Methylprednisolone while the test group receives phenol 8%.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Back Pain
Keywords
Methylprednisolone, trans sacral block, phenol

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
phenol
Intervention Description
1 cc of 8% phenol dissolved in water or 20cc of 8o mg Methylprednisolone diluted in 0.25% marcaine.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: -at least 18 years of age; chronic low back pain of at least 12 weeks duration; patients which were diagnosed as a candidate for epidural since other techniques have failed to provide adequate pain control Sciatica due to Lumbar Disc Herniation Neurogenic Claudication due to Lumbar Spinal Stenosis Exclusion Criteria: patients with unbalanced high blood pressure patients who can not ley prone patients who consumes anti-clotting medications patients with bleeding problems patients with Diabetes patients who suffers from chronic non-specific lower back and limb pain
Facility Information:
Facility Name
Assaf Harofeh Medical Center
City
Zerifin
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Murat Bahar, M.D
Phone
0577-345466
First Name & Middle Initial & Last Name & Degree
Josef Veltzer, M.D
Phone
052-3420815
First Name & Middle Initial & Last Name & Degree
Murat Bahar, M.D

12. IPD Sharing Statement

Learn more about this trial

Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs

We'll reach out to this number within 24 hrs